Skeletal muscle density is an independent predictor of diffuse large B‐cell lymphoma outcomes treated with rituximab‐based chemoimmunotherapy - Concepedia

Concepedia

Publication | Open Access

Skeletal muscle density is an independent predictor of diffuse large B‐cell lymphoma outcomes treated with rituximab‐based chemoimmunotherapy

DOI Full Paper Access

83

Citations

27

References

2016

Year

Michael P. Chu, Jessica Lieffers, Sunita Ghosh, Andrew R. Belch, Neil Chua, Amélie Fontaine, Randeep Sangha, Robert A. Turner, Vickie E. Baracos, Michael B. Sawyer

Journal of Cachexia Sarcopenia and Muscle

Abstract

SMD is a novel prognostic (and potentially treatment predictive) marker independent of R-IPI in DLBCL. It presents an inexpensive yet complementary assessment to R-IPI for prognosticating DLBCL outcomes.

References

	Year	Citations

Page 1